Table 9.
The distribution of Toxoplasma IgG seropositivity among various hematologic and solid malignancies.
| Cancer type | IgG seropositivity | P value | |
|---|---|---|---|
| Negative | Positive | ||
| Hematologic cancers | |||
| Acute lymphoblastic leukaemia | 7 (77.78%) | 2 (22.22%) | 0.28 |
| Non-Hodgkin lymphoma | 4 (44.44%) | 5 (55.56%) | |
| Hodgkin lymphoma | 2 (28.57%) | 5 (71.43%) | |
| Chronic lymphoblastic leukaemia | 1 (50.00%) | 1 (50.00%) | |
| Acute myeloid leukaemia | 1 (100%) | 0 | |
| Solid cancers | |||
| Breast cancer | 3 (27.27%) | 8 (72.73%) | 0.90 |
| Brain cancer | 1 (25.00%) | 3 (75.00%) | |
| Hepatocellular carcinoma | 1 (25.00%) | 3 (75.00%) | |
| Lung cancer | 0 | 2 (100%) | |
| Colon cancer | 0 | 1 (100%) | |
P value was calculated using the Chi square test.
P < 0.05 is statistically significant.